TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ANVS

Annovis Bio Inc

Healthcare · Biotechnology

1.40$ +5.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Annovis Bio Inc (ANVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -26 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ANVS
Line item 2010 2011 2012 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1.8 -3.0 -1.4 -0.5 -0.6 -0.5 -4.0 -9.1 -17 -40 -22 -26
0.0 0.3 0.0 – – 1.2 0.1 – – – – –
– – – 0.0 0.1 0.0 1.9 4.7 9.2 4.6 3.8 1.8
0.6 -3.3 8.8 0.0 0.1 0.1 1.9 4.7 – – – –
– – – 0.1 0.1 0.4 -0.4 0.7 -1.1 -0.2 0.7 1.6
0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
-1.0 -0.1 -0.1 – – – – – – – – –
6.7 0.0 0.0 0.3 0.2 – 12 47 – – – –
-0.2 0.2 0.2 0.5 0.5 0.5 – – – – – –
6.6 0.2 0.2 0.3 0.2 0.4 12 47 0.0 17 27 35
4.3 -3.0 -1.3 -0.2 -0.3 0.0 8.1 38 -17 -23 4.8 9.0
– – – -0.5 -0.6 -0.5 -4.0 -9.1 -17 -40 -22 -26

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?